Evidence map›Paper›PMID 40190319›Full record

ArticleArchives of medical science : AMS2025

Familial Mediterranean fever association with schizophrenia: insights from big data analysis.

Kassem Sharif, Abdulla Watad, Nicola Luigi Bragazzi, Yarden Yavne, Charlie Bridgewood, Dennis McGonagle, Doron Comanhester, Arnon D Cohen, Howard Amital

Abstract read
In one paragraph

Article in Archives of medical science : AMS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kassem SharifUniversity of Leeds, United Kingdom.
Abdulla WatadSheba Medical Centre, Israel.
Nicola Luigi BragazziUniversity of Genoa, Italy.
Yarden YavneSheba Medical Centre, Israel.
Charlie BridgewoodUniversity of Leeds, United Kingdom.
Dennis McGonagleUniversity of Leeds, United Kingdom.
Doron ComanhesterClalit Health Services, Israel.
Arnon D CohenClalit Health Services, Israel.
Howard AmitalSheba Medical Centre, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Several autoimmune diseases have been associated with schizophrenia; however, little is known about putative links with auto-inflammatory conditions. We investigated the association between familial Mediterranean fever (FMF), a paradigmatic auto-inflammatory disease, and schizophrenia and assessed the impact of the latter on the survival of FMF patients. Material and methods: A case-control study was performed by utilising the database of Clalit Health Services, the largest health maintenance organisation in Israel. Familial Mediterranean fever patients were compared to age- and sex-matched controls in terms of prevalence of schizophrenia. The χ Results: The study included 7747 FMF patients and 10,080 age- and sex-matched controls (case-control match 1 : 1.3). On univariate analysis, 50 FMF patients (0.6%) and 89 controls (0.9%) had schizophrenia. On multiple logistic regression model, FMF was inversely associated with schizophrenia (OR = 0.64 [95% CI: 0.43-0.90], Conclusions: Familial Mediterranean fever patients have a significantly lower proportion of schizophrenia than controls. The current evidence shows that auto-inflammatory conditions confer protection against schizophrenia development. Patients with either FMF or schizophrenia are at higher risk of all-cause mortality, a finding that calls for assessment of better medical management of mortality outcomes.

Indexed as

autoinflammationepidemiologyfamilial Mediterranean fever (FMF)schizophrenia

Identifiers

PMID40190319
PMCPMC11969521

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.